These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2412666)

  • 1. Behavioral and neurochemical effects of deprenyl and beta-phenylethylamine in Wistar rats.
    Greenshaw AJ; Juorio AV; Boulton AA
    Brain Res Bull; 1985 Aug; 15(2):183-9. PubMed ID: 2412666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depletion of striatal beta-phenylethylamine following dopamine but not 5-HT denervation.
    Greenshaw AJ; Juorio AV; Nguyen TV
    Brain Res Bull; 1986 Oct; 17(4):477-84. PubMed ID: 3096499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. beta-Phenylethylamine and reinforcement.
    Greenshaw AJ
    Prog Neuropsychopharmacol Biol Psychiatry; 1984; 8(4-6):615-20. PubMed ID: 6442439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The neurotoxic actions of 1-methyl-4-phenylpyridine (MPP+) are not prevented by deprenyl treatment.
    Bradbury AJ; Costall B; Jenner PG; Kelly ME; Marsden CD; Naylor RJ
    Neurosci Lett; 1985 Jul; 58(2):177-81. PubMed ID: 2413398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-regulation of beta-adrenergic and dopaminergic receptors induced by 2-phenylethylamine.
    Paetsch PR; Greenshaw AJ
    Cell Mol Neurobiol; 1993 Jun; 13(3):203-15. PubMed ID: 8242685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of monoamine oxidase-B by (-)-deprenyl potentiates neuronal responses to dopamine agonists but does not inhibit dopamine catabolism in the rat striatum.
    Paterson IA; Juorio AV; Berry MD; Zhu MY
    J Pharmacol Exp Ther; 1991 Sep; 258(3):1019-26. PubMed ID: 1679846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serotonin-mediated behavior in rats chronically treated with (-) deprenyl.
    Gyarmati S; Timar J; Knoll B; Knoll J
    Pol J Pharmacol Pharm; 1988; 40(6):667-71. PubMed ID: 2479936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrical stimulation of the substantia nigra and changes of 2-phenylethylamine synthesis in the rat striatum.
    Juorio AV; Paterson IA; Zhu MY; Matte G
    J Neurochem; 1991 Jan; 56(1):213-20. PubMed ID: 1670953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-propargylbenzylamine, a major metabolite of pargyline, is a potent inhibitor of monoamine oxidase type B in rats in vivo: a comparison with deprenyl.
    Karoum F
    Br J Pharmacol; 1987 Feb; 90(2):335-45. PubMed ID: 3103805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2-Phenylethylamine in combination with l-deprenyl lowers the striatal level of dopamine and prolongs the duration of the stereotypy in mice.
    Kitanaka J; Kitanaka N; Tatsuta T; Takemura M
    Pharmacol Biochem Behav; 2005 Nov; 82(3):488-94. PubMed ID: 16298423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of long-term treatment with selective monoamine oxidase A and B inhibitors on dopamine release from rat striatum in vivo.
    Lamensdorf I; Youdim MB; Finberg JP
    J Neurochem; 1996 Oct; 67(4):1532-9. PubMed ID: 8858937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Region-specific alterations in the concentrations of catecholamines and indoleamines in the brains of young and old F344 rats after L-deprenyl treatment.
    ThyagaRajan S; Stevens SY; Felten DL
    Brain Res Bull; 1999 Mar; 48(5):513-20. PubMed ID: 10372512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Possible mechanism of selective inhibition of rat liver mitochondrial monoamine oxidase by chlorgiline and deprenyl].
    Severina IS
    Biokhimiia; 1979 Feb; 44(2):195-207. PubMed ID: 435561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of some neuroleptics and d-amphetamine on striatal 2-phenylethylamine in the mouse.
    Juorio AV; Greenshaw AJ; Zhu MY; Paterson IA
    Gen Pharmacol; 1991; 22(2):407-13. PubMed ID: 1676007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic transformation plays a primary role in the psychostimulant-like discriminative-stimulus effects of selegiline [(R)-(-)-deprenyl].
    Yasar S; Justinova Z; Lee SH; Stefanski R; Goldberg SR; Tanda G
    J Pharmacol Exp Ther; 2006 Apr; 317(1):387-94. PubMed ID: 16352699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lesion-induced reductions in trace amine accumulation: dependence on MAO inhibitor pretreatment.
    Nguyen TV; Juorio AV; Greenshaw AJ
    Brain Res Bull; 1989 Feb; 22(2):197-200. PubMed ID: 2495844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Desynchronization of electrical activity in rats induced by deprenyl--an inhibitor of monoamine oxidase B--and relationship with selective increase of dopamine and beta-phenylethylamine.
    Dzoljic MR; Bruinvels J; Bonta IL
    J Neural Transm; 1977; 40(1):1-12. PubMed ID: 833580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of chronic oral administration of L-deprenyl in the dog.
    Milgram NW; Ivy GO; Murphy MP; Head E; Wu PH; Ruehl WW; Yu PH; Durden DA; Davis BA; Boulton AA
    Pharmacol Biochem Behav; 1995; 51(2-3):421-8. PubMed ID: 7667363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. L-deprenyl inhibits tumor growth, reduces serum prolactin, and suppresses brain monoamine metabolism in rats with carcinogen-induced mammary tumors.
    ThyagaRajan S; Quadri SK
    Endocrine; 1999 Jun; 10(3):225-32. PubMed ID: 10484286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of functional down-regulation of beta-adrenoceptors in rats by 2-phenylethylamine.
    Paetsch PR; Baker GB; Greenshaw AJ
    J Pharm Sci; 1993 Jan; 82(1):22-4. PubMed ID: 8381487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.